Rob Read Maxwell Finland Award_475x220
Congratulations to Professor Robert Read for being the first non-US clinician asked to give the 45th annual Maxwell Finland Award Lecture at the Infectious Disease Society of America.
Professor Robert Read, the Director-designate of the new NIHR Southampton Biomedical Research Centre, gave the 45th annual Maxwell Finland Award Lecture on 27 October 2016 at the Infectious Disease Society of America in New Orleans.
A great honour
Each year, the Maxwell Finland Award Lectureship is given by a clinical scientist who has made outstanding contributions to clinical science in infectious disease. Professor Read is the first non-US clinician to be accorded this honour.
Maxwell Finland, after which the lectureship is named, served as the first president of the Infectious Disease Society of America. His prestigious medical career spanned more than 50 years at Harvard University and Boston City Hospital.
He was internationally recognized for his study of the incidence and character of infectious diseases and their specific treatments, and is credited with influencing the pioneering of studies of antibiotic therapy and establishing early identification of new infectious hazards.
Professor Read is a world renowned academic infectious disease physician with more than 25 years of experience in research. He is Professor of Infectious Diseases at the University of Southampton, Head of Academic Unit of Clinical & Experimental Sciences, and Honorary Consultant Physician to University Hospital Southampton.
He has made major international contributions in infectious diseases research, translation and policy, reflected in his prior role as chair of the European Society for Clinical Microbiology and Infectious Disease Science Committee and election to their executive council. He was elected a Fellow of the Infectious Disease Society of America in 2008.
He recently led the bid by University Hospital Southampton for the new NIHR Biomedical Research Centre, which resulted in a successful outcome and award of £15 million by the Department of Health and National Institute of Health Research. He will be the Director of the NIHR BRC commencing April 2017.
Posted on Tuesday 22 November 2016